When should low‑dose aspirin (81 mg) be initiated in pregnant women at increased risk for preeclampsia?

Low-Dose Aspirin for Preeclampsia Prevention

Low-dose aspirin (81 mg daily) should be initiated between 12 and 28 weeks of gestation, optimally before 16 weeks, in pregnant women at high risk for preeclampsia and continued until delivery.

Who Should Receive Aspirin

Multiple major guidelines converge on recommending aspirin for women with high-risk factors 1, 2:

High-Risk Factors (One or More Required):

• History of preeclampsia, especially early-onset preeclampsia with delivery <34 weeks
• History of preeclampsia in more than one prior pregnancy
• Chronic hypertension
• Type 1 or type 2 diabetes
• Renal disease
• Autoimmune disease (e.g., lupus, antiphospholipid syndrome)
• Multifetal gestation

Moderate-Risk Factors (Two or More May Warrant Treatment):

• First pregnancy
• Maternal age ≥35-40 years
• Body mass index ≥30-35 kg/m²
• Family history of preeclampsia
• Pregnancy interval >10 years
• Sociodemographic risk factors

The ACOG and Society for Maternal-Fetal Medicine endorse the USPSTF criteria, which support aspirin use in women with one high-risk factor or multiple moderate-risk factors 2.

Timing of Initiation: Critical for Efficacy

The timing of aspirin initiation is absolutely critical. The evidence strongly demonstrates that aspirin started at ≤16 weeks of gestation provides substantially greater benefit than later initiation 3, 4:

• Started ≤16 weeks: Reduces preeclampsia risk by 47-53% (RR 0.47-0.53)
• Started >16 weeks: Reduces preeclampsia risk by only 22-24% (RR 0.76-0.78)

Meta-analysis data show that early initiation (≤16 weeks) significantly reduces 4:

• Preeclampsia (RR 0.47)
• Fetal growth restriction (RR 0.46)
• Preterm birth (RR 0.35)
• Perinatal death (RR 0.41)

When started after 16 weeks, these benefits are substantially diminished or lost entirely 4.

Practical recommendation: Initiate aspirin as soon as high-risk status is identified, ideally during the late first trimester (12 weeks) but no later than 16 weeks for optimal benefit 1, 2.

Dosage Considerations

The standard recommended dose in the United States is 81 mg daily 1, 2. This recommendation is based on:

• ACOG guidelines: 60-80 mg/day (81 mg is the standard available dose) 1, 2
• USPSTF: Supports 81 mg/day 1
• American Academy of Family Physicians: 81 mg/day 1

The Dosage Debate

There is ongoing debate about whether higher doses (150-162 mg) might be more effective 5, 3:

• Some international guidelines (UK NICE, Royal College of Obstetricians and Gynaecologists) recommend 75-150 mg 5
• Meta-analyses suggest doses ≥100 mg may provide greater benefit, particularly when started early 3, 4
• Recent research indicates a possible 78% probability of additional benefit with 162 mg versus 81 mg in high-risk obese individuals, though this did not reach definitive statistical significance 6

However, current high-quality evidence does not justify routinely using higher doses in the U.S. context 7. The 81 mg dose remains the standard recommendation until larger randomized trials demonstrate clear superiority of higher doses 7.

Special Consideration for Obesity

In obese patients (BMI ≥30 kg/m²), there may be inadequate dosing or aspirin resistance with 81 mg 6. While one recent trial showed a trend toward benefit with 162 mg in this population, the evidence is not yet definitive enough to change practice 6. Consider 81 mg as standard, but recognize this is an area of active investigation.

Duration of Treatment

Continue aspirin daily until delivery 1, 2. Do not discontinue prematurely, as the protective effect requires sustained use throughout pregnancy.

Safety Profile

Low-dose aspirin in pregnancy has a favorable safety profile 2:

• No increased risk of placental abruption (contrary to older concerns)
• No increased risk of neonatal intracranial hemorrhage 8
• Possible slight increase in postpartum hemorrhage risk, though this remains debated 3, 8
• Overall, the benefits substantially outweigh the minimal risks in high-risk populations

The FDA label notes caution with aspirin use, particularly in the third trimester for general indications 9, but this does not apply to the specific low-dose prophylactic use for preeclampsia prevention, which is supported by extensive evidence.

Common Pitfalls to Avoid

1. Starting too late: Initiating aspirin after 16 weeks dramatically reduces efficacy. Screen for risk factors early in prenatal care.

2. Underdosing: Ensure patients take the full 81 mg daily, not "baby aspirin" products with lower doses.

3. Inconsistent adherence: Emphasize the importance of daily use without interruption.

4. Missing moderate-risk patients: Don't overlook women with multiple moderate-risk factors who may also benefit.

5. Premature discontinuation: Continue until delivery, not just until term.